Evaluating the costs of glycemic response with canagliflozin versus dapagliflozin and empagliflozin as add-on to metformin in patients with type 2 diabetes mellitus in the United Arab Emirates-Reference-Cited by-同舟云学术

Evaluating the costs of glycemic response with canagliflozin versus dapagliflozin and empagliflozin as add-on to metformin in patients with type 2 diabetes mellitus in the United Arab Emirates

Published:2017-04-28 Issue:6 Volume:33 Page:1155-1163
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Schubert Agata¹,Buchholt Anders T.²,El Khoury Antoine C.³,Kamal Ahmed³,Taieb Vanessa⁴

Affiliation:

1. Janssen-Cilag Poland, Warsaw, Poland;

2. Janssen-Cilag A/S, Birkerød, Denmark;

3. Janssen-Cilag, Dubai, UAE;

4. Amaris, London, UK

Funder

Janssen Pharmaceutica NV

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2017.1310091

Reference82 articles.

1. International Diabetes Federation: Middle East and North Africa. United Arab Emirates. 2016. Available at: http://www.idf.org/membership/mena/united-arab-emirates. Last accessed February 22, 2017

2. International Diabetes Federation. IDF Diabetes Atlas 6th Edition: 2014 Update. Brussels, Belgium: International Diabetes Federation, 2015

3. Central Intelligence Agency. The World Factbook: United Arab Emirates. 2015. Available at: https://www.cia.gov/library/publications/the-world-factbook/geos/ae.html. Last accessed February 22, 2017

4. Assessment of the direct medical costs of diabetes mellitus and its complications in the United Arab Emirates

5. International Diabetes Federation. IDF Diabetes Atlas, 2012 Update. Brussels, Belgium: International Diabetes Federation; 2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Efficacy and Safety Profile of Sodium-Glucose Cotransporter-2 Inhibitors as Add-On Therapy in Patients With Type 2 Diabetes;Cureus;2021-04-03

2. Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Council countries;Expert Review of Pharmacoeconomics & Outcomes Research;2018-05-30

3. Pioglitazone/metformin adduct regulates insulin secretion and inhibits high glucose‐induced apoptosis via p21‐p53‐MDM2 signaling in INS‐1 cells;Journal of Cellular Biochemistry;2018-04-10

4. Cost-Effectiveness Analysis of Canagliflozin 300 mg Versus Dapagliflozin 10 mg Added to Metformin in Patients with Type 2 Diabetes in the United States;Diabetes Therapy;2018-02-06